Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today...

Related Keywords

Sharon Klahre , Linkedin , Syndax Pharmaceuticals , Company On Twitter , Nasdaq , Syndax Pharmaceuticals Inc , Nc ,